Utility of comprehensive genomic profiling in directing treatment and improving patient outcomes in advanced non-small cell lung cancer

Utility of comprehensive genomic profiling in directing treatment and improving patient outcomes in advanced non-small cell lung cancer

Abstract Background With the identification of new targetable drivers and the recent emergence of novel targeted drugs, using comprehensive genomic profiling in lieu of the routine testing for classic drivers in the clinical care for advanced NSCLC has been increasingly advocated. However, the key a...

Full description

Bibliographic Details
Main Authors: Shen Zhao, Zhonghan Zhang, Jianhua Zhan, Xin Zhao, Xinru Chen, Liyun Xiao, Kui Wu, Yuxiang Ma, Mengzhen Li, Yunpeng Yang, Wenfeng Fang, Hongyun Zhao, Li Zhang
Format: Article
Language:English
Published: BMC 2021-10-01
Series:BMC Medicine
Subjects:
Precision oncology
Comprehensive genomic profiling
Genotype-matched therapies
Biomarker-selected trials
Non-small cell lung cancer
Online Access:https://doi.org/10.1186/s12916-021-02089-z

Internet

https://doi.org/10.1186/s12916-021-02089-z

Similar Items